Challenges in the Pharmacogenomic Annotation of Whole Genomes
- 24 May 2013
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 94 (2) , 211-213
Abstract
Next‐generation sequencing technologies have enabled the sequencing of an entire genome for less than $4,000. With access to all the genetic variation in an individual, our task will be to use this information to assess the genetic influences on drug efficacy, toxicity, and dosage. Clinical Pharmacology & Therapeutics (2013); 94 2, 211–213. doi:10.1038/clpt.2013.111Keywords
This publication has 6 references indexed in Scilit:
- Pharmacogenomics Knowledge for Personalized MedicineClinical Pharmacology & Therapeutics, 2012
- Personal Omics Profiling Reveals Dynamic Molecular and Medical PhenotypesCell, 2012
- Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference SequencePLOS Genetics, 2011
- Pharmacogenetics: From Bench to Byte— An Update of GuidelinesClinical Pharmacology & Therapeutics, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- Clinical assessment incorporating a personal genomeThe Lancet, 2010